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CHAPTER I 
1. Background and Significance 
For centuries prosthetic appliances were fabricated to replace lost teeth, soft and hard 
tissue loss (Powers, 2006). A variety of materials have been used, from vulcanite and 
porcelain teeth to microwavable methyl-methacrylate and highly resistant resin teeth, 
which were developed and evolved to improve materials properties and biocompatibility 
(Grant, 1980; Watanabe et al., 1999; Starcke, 1975). Ever improving techniques of 
prosthesis fabrication have delivered excellent function capability to masticate and 
esthetics for social acceptance in any environment, restoring for patients what was once 
lost. 
Over the past four decades implant dentistry has been providing exciting possibilities for 
a "third dentition", enabling great improvement of masticatory function, esthetics, hard 
and soft tissue maintenance. The development of Guided Bone Regeneration and Guided 
Tissue Regeneration, CT Scans, CAD-CAM imaging systems and computer technologies 
greatly enhanced treatments for patients who experienced extreme bone and soft tissue 
loss. With the advancement of grafting techniques to properly accommodate implant-
supported restorations, dental implants gave patients a "third chance" to achieve proper 
function and esthetics. However, much effort, resources and time are spent on lengthy 
therapy to construct prosthetic devices that need frequent maintenance and are technique 
sensitive, with the potential of causing more tissue loss when failure occurs. 
Today research is focused in the field of Tissue Engineering as the avenue for the 
regeneration of lost structures and tissues damaged by trauma, cancer and other diseases. 
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Advancements in the molecular biology field and stem cell technology are uncovering 
new horizons in therapeutic possibilities for the tissue and organ replacement. 
Tissue engmeermg uses a combination of three elements: cells, scaffolds and 
morphogenic signals. Tissue engineering is an interdisciplinary field that applies the 
principles of engineering and life sciences to the development of biological substitutes 
that restore, maintain, or improve tissue function or a whole organ (Langer and Vacanti, 
1993). 
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2. Purpose and Hypothesis 
The purpose of this study was to characterize a model for dental pulp tissue engineering 
that is based on the implantation of dental pulp stem cells in tooth slice/scaffold devices. 
The hypothesis ofthis study is: 
Seeding of Human Dental Pulp Stem Cells in a biodegradable scaffold within the pulp 
chamber of a human tooth slice allows for the engineering of a tissue with cellularity 
similar to the dental pulp. 
Our hypothesis will be tested through the following three specific aims: 
Specific Aim 1: To characterize a model system to culture dental pulp stem cells in a 
biodegradable scaffold inside the canal of a tooth. 
Specific Aim 2: To evaluate the cellular proliferation and spatial distribution inside the 
tooth slice/scaffold system in vitro. 
Specific Aim 3: To evaluate the morphological characteristics ofthe dental pulp-like 
tissue engineered within the tooth slices in vivo. 
Null hypothesis: 
Seeding of Human Dental Pulp Stem Cells in a biodegradable scaffold within the pulp 
chamber of a human tooth slice does not allow for the engineering of a tissue with 
cellularity similar to the dental pulp. 
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3. Literature Review 
A. Tissue Engineering 
Twenty years ago, Charles Vacanti and Robert Langer from the Harvard Medical School 
published a classical article describing the concept of tissue engineering. The first 
recorded use of the term tissue engineering was in an article entitled "Functional Organ 
Replacement: The New Technology of Tissue Engineering", published in Surgical 
Technology International in 1991 (Vacanti et al., 1991). Since then, the Tissue 
Engineering Society (TES) and Journal was founded in 1994 to help guide its purposes 
and vision for the future of this field. The Tissue Engineering Society was officially 
incorporated in the state of Massachusetts on January 8, 1996, with its founding 
Presidents Drs. Charles and Joseph Vacanti, as well as Dr. Robert Langer of MTI 
(Vacanti, 2006). 
A pediatric orthopedic surgeon at the Children's Hospital, W.T. Green, performed a 
number of experiments in the early 1970's to generate new cartilage using chondrocytes 
seeded onto bone spicules and implanted in nude mice (Langer et al., 1991). Although 
unsuccessful with the experiment, he correctly concluded that with innovative 
biocompatible materials, it would be possible to generate new tissue by seeding viable 
cells onto scaffolds. Later at Massachusetts General Hospital and M.I.T., Dr. Burke and 
Dr. Yanas generated a skin substitute using a collagen matrix to support the growth of 
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dermal fibroblasts. Dr. Howard Green transferred sheets of keratinocytes onto bum 
patients, while Dr. Eugene Bell seeded collagen gels with fibroblasts (Bell et al., 1991 ). 
In the mid 1980's, Drs. Joseph Vacanti and Robert Langer designed and implemented 
scaffoldings synthetically fabricated in the laboratory that had physical and chemical 
properties that could be manipulated; they were biocompatible and biodegradable 
polymers as carriers of viable cells. Their original article describing the new technology 
was published in 1988 in Archives of Surgery (Vacanti, 2006) based on a keynote 
presentation given at the American College of Surgeons Meeting. 
The trilogy of tissue engineering is cells, morphogenic signals, and a scaffold (Langer 
and Vacanti, 1993). Suitable biochemical factors, namely growth factors, give the 
morphogenic signals to the cells that will improve or replace biological functions within 
the newly formed tissue. 
B. Engineering of Tooth Structures 
In 2002, Young and collaborators dissociated porcine third molar tooth buds into single 
cell suspensions, and seeded onto biodegradable polymers, letting them grow in rat hosts 
for 20 to 30 weeks. The results were recognizable tooth structures containing dentin, 
odontoblasts, a well-defined pulp chamber, putative Hertwig's root sheath epithelia, 
cementoblasts and morphologically correct enamel organ, containing fully formed 
enamel. Their study demonstrated a successful generation of tooth crowns from 
dissociated tooth tissues, and they suggested the presence of epithelial and mesenchymal 
stem cells in porcine third molar tissues (Young eta!., 2002). 
6 
C. Stem Cells 
The "Toti Potenti" embryonic stem cell generated much ethical concerns when used in 
laboratory experiments. With further research, a generation of stem cells were found in 
several tissues of adult humans, offering an excellent alternative for the exploration of 
stem cell therapy with similar differentiation characteristics when compared to embryonic 
stem cells, without the ethical concerns associated with it. 
Adult stem cells have unique characteristics. They exist as undifferentiated cells and 
maintain this phenotype by the environment and/or the adjacent cell populations until 
they are exposed to and respond to the appropriate signals, have the ability to self-
replicate for prolonged periods and maintain their multiple differentiation potential 
throughout the life of the organism. Progenitor cells retain the differentiation potential 
and high proliferation capability, but have lost the self-replication property unlike stem 
cells (Barry 2003). 
Bone marrow stem cells are being used for marrow transplants in cases of leukemia and 
some other cancers (Tabbara et al., 2002). Current investigation is being studied for 
direct injection of stem cells into the heart after myocardial infarction to produce 
cardiomyocytes (Stamm et al., 2003). Stem cells have also been applied in the 
regeneration of liver (Petersen et al., 1999), hone (Derubeis and Cancedda, 2004), kidney 
(Imai and Ito, 2002), and neurons in the central nervous system (Okano, 2002). 
Muscle-derived stem cells are being used to regenerate muscle, bone and blood cells. 
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Mesenchymal stem cells are capable of specific migration to sites of injury, for example, 
in bone fractures (Mosca et al., 2000; Devine et al., 2002), myocardial infarction (Shake 
et al., 2002), ischemic cerebral injury and knee joint injury (Murphy et al., 2003). They 
are also used in skin grafts and vascular grafts (Gronthos et al., 2002). The mechanisms 
that guide homing of injected or implanted cells, however, remain unclear. 
There is much interest on the utility of cell and gene therapy for regeneration (Pomerantz 
and Blau, 2004; Wagers and Weissman, 2004). 
D. Dental Pulp Stem Cells 
Stem cell niches were identified in a number of tissues including skin, hair follicles, bone 
marrow, intestine, brain, pancreas and more recently, in dental pulp (Liu et al., 2006). This 
offers an excellent alternative to the exploration of multi potent cells capable of being 
isolated, cultured in vitro, and differentiated into other cells and tissues such as dentin, bone, 
smooth muscle, neural, endothelial and adipose tissue, without the ethical concerns 
associated with embryonic stem cell research. Dental pulp stem cells were collected from 
clinically extracted human teeth and enzymatically released from the pulp tissue (Liu et al., 
2006). 
Paul Sharpe's group at the GTK Dental Institute in London has been studying the 
interactions of non dental cell derived mesenchyme and embryonic oral epithelium that 
stimulated odontogenic response in the stem cells (Ohazama et al., 2004) (Sharpe and 
Young, 2005). A group from the Craniofacial and Skeletal Diseases Branch of the National 
Institute of Health-USA was able to identify in adult human dental pulp, in human primary 
teeth and in periodontal ligament, stem cells that were highly clonogenic and able to be 
8 
cultured in vitro, forming cell clusters (Gronthos et al., 2000). These cells were expanded ex 
vivo and expressed a heterogeneous assortment of markers associated with mesenchymal 
stem cells, dentin, bone, smooth muscle, adipose and neural tissue. They are often found in 
highly vascularized sites. A study, using several markers of the microvasculature networks, 
has suggested that pulp stem cells are intimately associated with the blood vessels of pulp 
tissue, especially pericytes and smooth muscle cells (Shi and Gronthos, 2003). Both 
supportive connective tissues of bone marrow and dental pulp contain stromal stem cell 
populations with high proliferative potential, capable of regenerating their respective 
microenvironments with remarkable fidelity, including the surrounding mineralized bone 
and dentin (Gronthos et al., 2000; Gronthos et al., 2002). The demonstration of specific 
markers of dental pulp stem cell differentiation pathways is still under investigation. Also, 
their characteristics and gene expression patterns in vitro might be different than in situ. 
Dental pulp stem cells were able to differentiate and secrete a matrix that produces 
osteogenesis and dentinogenesis in vitro and in vivo, with small teeth produced in vivo, but 
with a disorganized dentinal-pulpal complex (Miura et al., 2003). This could be related to 
the inability of these cells to produce adequate and organized vascularized network in vitro 
(Tepper et al., 2003). 
E. Growth factors relevant for pulp biology 
In the angiogenic process of the pulp of mature teeth, new capillary formation was 
identified as occurring directly underneath the odontoblastic layer, through the regulatory 
effect of growth factors. Examples of growth factors involved in pulp biology are several 
members of the transforming growth factors (TGF-B), the bone morphogenic proteins 
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(Bmp-2, 4, 7, 11); fibroblast growth factor (FGF); insulin growth factor (IGF); vascular 
endothelial growth factor (VEGF), and others, expressed by odontoblasts, fibroblasts and 
other cell types, or released from the dentin (Sloan, Rutherford et al. 2000) (Delespesse et 
al., 1996). 
Bone morphogenic proteins (BMP) family members are sequentially involved in 
embryonic tooth development (Nakashima and Reddi, 2003; Nie et al., 2006). The 
interactions between epithelium and mesenchyme are essential in tooth development 
(Nakashima and Akamine, 2005) (Sharpe and Young, 2005). Bmp 4 from the epithelium 
induces the mesenchyme to be odontogenic (Ohazama et al., 2005). Bmp2, Bmp4, and 
Bmp7 signals expressed in the enamel knot influence both epithelial and mesenchymal 
cells and are responsible for the maintenance of the enamel knot and the subsequent 
morphogenesis of epithelium (Thesleff, 2003) (Reddi, 1998). These signals also regulate 
the patterning of the tooth crown by influencing the initiation of the secondary knots 
together with mesenchymal signals such as Bmp 4 (Mikkola et al., 2002). Bmp 2, Bmp 4, 
Bmp 6, Bmp 7, and Bmp 11 are also expressed during odontoblast differentiation and Bmp 
4 and Bmp 5 during ameloblast differentiation (Aberg et al., 1997; Nakashima et al., 
1999). Such knowledge has been applied in tissue engineering of tooth structures by 
several authors (Ohazama et al., 2005) (Nakashima and Reddi, 2003) (Nie et al., 2006) 
(Zhang et al., 2005). 
Dentin matrix contains a cocktail of biologically active molecules with a wide range of 
effects (Smith et al., 1998). Several growth factors are expressed in the dentin 
(Finkelman et al., 1990; Cassidy et al., 1997), as well as angiogenic cytokines (Roberts-
Clark and Smith, 2000). Release of these growth factors could account for the increased 
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local angiogenesis observed at sites of dental tissue repair (Baume, 1980); (Smith et al., 
1990) (Schroder, 1985) (Roberts-Clark and Smith, 2000), and in the pulps of 
orthodontically moved teeth, where they might mediate local angiogenic responses 
(Derringer et al., 1996; Derringer and Linden, 1998). 
F. Scaffolds 
Scaffolds provide a physicochemical and biological three-dimensional microenvironment 
for cell growth and differentiation, promoting cell adhesion, and migration (Nakashima 
and Akamine, 2005). The scaffold serves as a carrier for morphogens in protein therapy 
and for cells in cell therapy. Scaffold material should allow for transport of nutrients, 
oxygen, and waste. lt should be gradually degraded and replaced by regenerative tissue, 
retaining the feature of the final tissue structure. They should be biocompatible, nontoxic 
and have proper physical and mechanical strength. Natural polymers such as collagen and 
glycosaminoglycan offer good biocompatibility and bioactivity, and synthetic polymers 
can emulate physicochemical features such as degradation rate, microstructure, and 
mechanical strength. Commonly used synthetic materials are poly-L-lactic acid (PLLA), 
poly-glycolic acid (PGA), and their copolymers, poly-lactic-co-glycolic acid (PLGA). 
Scaffolds containing inorganic compounds such as hydroxyapatite and calcium phosphate 
are used to enhance bone conductivity (Jadlowiec et al., 2003). 
A major parameter in tissue regeneration is the choice of a suitable carrier. Ceramics, 
polymers and collagen matrices have all been used as substrates to culture dental pulp 
cells in vitro and in vivo (Zhang et al., 2006). Among these, calcium phosphate materials 
have been widely used because of good biocompatibility and their ability to support the 
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formation of hard tissue. Hydroxyapatite, calcium-B-glicerophosphate and a or B-
tricalcium phosphate were proven able to induce hard tissue formation when used as 
pulp-capping agents (Tziafas et al., 2002). Titanium fiber mesh is a highly biocompatible 
material, and even though it is not biodegradable it was not shown to be disadvantageous 
for hard tissue applications. Titanium fiber mesh, which has been used for bone 
regeneration, also supported the attachment, growth and differentiation of dental pulp 
cells (Zhang et al., 2006). Titanium as well as calcium phosphate ceramic exerted little 
influence on the differentiation pattern of the cells toward an odontoblastic phenotype 
(Zhang eta/., 2005). 
Different scaffolds can stimulate different behavior from the same cell population due to 
its chemical and physical properties, and spatial availability, having an important role in 
the engineering of tissues (Zhang eta/., 2006). 
G.In vitro and in vivo studies on dental pulp regeneration 
Cultured adult dental pulp stem cells (DPSC) demonstrated the ability to generate a 
dentin/pulp-like complex in vivo when co-transplanted with hydroxyapatite and tri-
calcium-phosphate (HA/TCP) particles subcutaneously into immunocompromised mice 
(SCID mice) (Shi and Gronthos, 2003) (Shi and Gronthos, 2003).. Typical DPSC 
transplants developed areas of vascularized pulp tissue surrounded by a well-defined 
layer of odontoblast-like cells, aligned around mineralized dentin with their processes 
extending into tubular structures. In addition, orientation of the collagen fibers within the 
dentin was characteristic of ordered primary dentin, perpendicular to the odontoblast 
layer (Shi and Gronthos, 2003). 
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Adult vasculogenesis was demonstrated in mice to be initiated as a response to local 
tissue ischemia that releases growth factors such as VEGF and others, responsible to 
mobilize endothelial progenitor cells (Tepper et al., 2005). In vivo stimuli to the hypoxic 
implant site and the wound healing process will stimulate microvascular formation inside 
and around the scaffold/tooth structure, maintaining and remodeling the newly formed 
tissue (Tepper et al., 2005). 
Recent data suggest that the capacity and potential for adult stem cells to differentiate 
into a wider spectrum of phenotypes, 'stem cell plasticity', is caused by fusion of stem 
cells with endogenous tissue-specific cells (Camargo et al., 2004; Wagers and Weissman, 
2004). Huang et al. characterized the human adult dental pulp cell differentiation 
potential grown in mechanically and chemically treated dentin and stimulated with 
dexamethasone that produced mineral nodules. They appeared to establish an 
odontoblast-like morphology, with cytoplasmic processes extending into dentinal tubules 
revealed by scanning electron microscopy analysis. Their data suggest that isolated 
human pulp stem cells may differentiate into odontoblasts on dentin in vitro (Huang et 
al., 2006). 
Tran-Hung et al. reported that Human Pulp Fibroblasts from third molars co-cultured 
with human umbilical vein endothelial cells induced the organization of endothelial cells 
into forming tubular structures corresponding to capillaries in vivo (Tran-Hung et al., 
2006). The direct contact between both cell types was not necessary to induce 
angiogenesis. The observed effect was due to soluble factors, confirmed with 
neutralizing antibodies against FGF -2 and VEGF, altering its effect once neutralized. 
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These results suggest that pulp fibroblasts secrete angiogenic factors, necessary for pulp 
healing (Tran-Hung et al., 2006). 
Another study reported co-expression of desmossomal proteins and vimetin in a specific 
mesenchymal phenotype (Sawa et al., 2005). This study investigated the expression of 
vimetin-binding desmossomal proteins in human dental pulp fibroblasts and odontoblasts. 
Through confocal laser-scanning microscopy, the difuse distribution of desmoplakin 
(DPK) was demonstrated in the cytoplasm throughout the odontoblastic processes. 
Dental pulp fibroblasts and odontoblast-like cells that were cultured had mRNA 
expression of osteocalcin (OCN) and dentinsialophosphoprotein (DSPP) established in 
the differentiation medium (Sawa et al., 2005). The pulp fibroblasts become odontoblast-
like cells expressed vimetin, but not desmoplakin before culturing in the differentiation 
medium. This suggests that dental pulp fibroblasts that usually express desmoplakin 
mRNA, and that the desmoplakin I production and the bonding of vimetin to 
desmoplakin 1 occur when dental pulp fibroblasts (DFP) are differentiating into 
odontoblast-like cells (Mooney et al., 1996; Sawa et al., 2005). Fibroblasts may help 
induce the formation of an engineered pulp tissue, along with human dental pulp stem 
cells, placed inside a scaffold in the pulp chamber of a sliced tooth, in vivo. 
H. The Odontoblast Phenotype 
The odontoblast phenotype has been mainly characterized by biochemical analyses ofthe 
dentin matrix that correspond to terminal differentiation markers. Odontoblasts secrete 
type I collagen and other non collagenous proteins such as osteonectin, osteopontin, 
bonesialoprotein, dentin phosphoryn, dentinsialoprotein and dentin matrix protein I 
14 
(Priam et al., 2005). This group analyzed the phenotypes of three independent clonal cell 
lines from first molar tooth germs of day 18 mouse embryos with RT-PCR and Western 
Blot. These clones synthesized dentinsialoprotein (DSP), dentin matrix protein 1 (DMP-
1) and other extracellular matrix proteins typical of the odontoblasts. However, gene 
expression patterns and signaling pathways underlying odontoblast differentiation are 
still unclear (Priam et al., 2005). In a study of differentiation potential of rat dental pulp 
cells, the authors state that dentinsialoprotein (DSP) and dentinphosphoprotein (DPP) 
form the major part of dentin noncollagenous proteins (Zhang et al., 2005). The 
expression of dentinsialoprotein (DSP), an odontoblast-specific marker, was restricted to 
the outer pulp layer containing mature odontoblasts and was absent in fibrous tissue, 





Dentistry has no adequate therapeutic strategies for a number of conditions involving 
pulp necrosis, especially in young permanent teeth with incomplete root formation. 
These teeth might benefit from the regeneration of dental pulp tissue thereby allowing for 
the completion of root formation. The objective of this study was to develop and 
characterize a new strategy involving tissue engineering based approaches and stem cells 
to regenerate a viable dental pulp tissue. Freshly extracted human teeth were cut into 1 
mm thick cross sections. The pulp tissue was removed and a synthetic biodegradable 
scaffold made with Poly-L-Lactic-Acid (PLLA) was cast in the root canal space of the 
tooth slice. These tooth slice/scaffold devices were disinfected in grades of ethanol, 
treated with 10% EDTA, washed in IX PBS, and were immediately seeded with human 
dental pulp stem cells (DPSC) and/or human dental pulp fibroblasts (DPF). Cellularity 
was evaluated after 1 to 7 days of cell culture in vitro. In tooth slices seeded with DPSC 
and DPF, we observed cellular processes extending into the dentinal tubules, suggestive 
of odontoblastic differentiation. This model system was also tested in vivo. Tooth slices 
containing human dental pulp stem cells and/or human dental pulp fibroblasts were 
implanted in the subcutaneous dorsal region of severely compromised immunodefficient 
mice (SCID mice). Mice were euthanized after 21 days and samples analyzed by 
histology with H&E staining and immunohistochemistry for Factor VIII to evaluate 
dental pulp vascularization. Histological examinations showed that the co-implantation of 
DPSC and DPF in tooth slices allowed for the engineering of a dental-pulp like tissue. 
We conclude that dental pulp stem cells might be useful to engineer a dental pulp-like 
tissue in young permanent teeth with incomplete root formation in the future. 
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2. Introduction 
Despite the high success rate of root canal therapy (97% after 8 years follow up), many 
teeth are not restorable due to apical resorption and fracture, incompletely formed roots 
or carious destruction of coronal structures (Salehrabi and Rotstein, 2004). For four 
decades, implant dentistry has provided a "third dentition" to patients who suffered the 
loss of teeth and soft tissues by surgically and prosthetically using titanium fixtures 
placed inside bony structures ofthe patient's mouth and face. Patients with severe bone 
loss in several areas of the mouth represented serious limitation for this treatment. This 
motivated the search for solutions to properly place implants in restorable areas, leading 
to the development of graft materials as well as Guided Bone Regeneration and Soft 
Tissue Regeneration. 
Today we take a step further as we look at the tooth as the first organ that might be 
feasible to engineer (Sharpe and Young, 2005; Zhang et al., 2005; Nor, 2006). With 
recent advances in molecular biology sciences and regeneration strategies with stem cells, 
the application of biologically based tissue engineering approaches to promote 
regeneration of tooth structures might provide exciting novel therapeutic possibilities in 
the restorative and endodontic fields (Tziafas, 2004). 
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3. Materials and Methods 
A. Cell Culture 
Dental Pulp Stem Cells (gift from Dr. Songtao Shi, University of Southern California) 
were cultured in low glucose Dulbecco's Modified Eagle Medium (DMEM; Gibco, 
Grand Island, NY, USA), supplemented with 10% Fetal Bovine Serum (Gibco), 275 
units/ml Penicillin and Streptomycin in a humidified C02 incubator at 37 ° C. Cell 
culture medium was changed every other day. When cells were confluent, they were 
detached from the 75ml flasks with Trypsin (Gibco), centrifuged, and passed at a 
proportion of 1:3. These cells remain active until approximately passage 20, undergoing 
senescence after that. All experiments were performed with cells between passage 5 and 
8. 
B. Preparation of tooth slices: 
Freshly extracted human third molars were collected from patients aged 15 through 28, 
undergoing surgical extractions in the Oral Surgery Clinic at the School of Dentistry -
University of Michigan for orthodontic reasons. The teeth were transported in low 
glucose Dulbecco's Modified Eagle Medium (DMEM; Gibco, Grand Island, NY, USA), 
supplemented with 10% Fetal Bovine Serum (Gibco ), 275 units/ml Penicillin and 
Streptomycin to the laboratory, cleaned of gingival tissue, POL and debris with sterile 
periodontal scalers, and prepared to be cut in 1.0 mm crossectional slices using a 
diamond blade 303 Series (MK -303 Professional- MK DIAMOND PRODUCTS INC., 
Torrance, CA) in the Isomet Low Speed Saw (Model 650, South Bay Technology, INC. 
Japan), cooled with IX PBS (Phosphate Buffered Saline; Cellgro, Mediatech, Inc. 
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Herndon, VA). The original pulp tissue was removed from the slice with a sterile #12 
Bard Parker scalpel, preserving the pre-dentin area. Each cut slice was placed 
immediately in 12 well plates containing 1 ml per well of PBS-1 X - Phosphate- Buffered 
Saline (Cellgro - Mediatech, Inc. Herndon, VA) and maintained at 4 ° C. All procedures 
were performed under aseptic conditions to avoid contamination. Collection of tooth 
slices was performed under a University of Michigan approved IRB protocol. 
C. Scaffold Fabrication Inside the Tooth Slices: 
A solution of five percent of Poly-L-Iactic acid (PLLA) scaffolds were prepared inside 
the pulp chamber tooth slices. The detailed description of this protocol is in the Appendix 
section. Tooth slice/scaffolds were rehydrated in 100% ethanol for 10 min, 90% ethanol 
for 1 Omim, 80% ethanol for 10 min, 70 % ethanol for 10 min. This was followed by an 
incubation in sterile 1 X PBS for 1 hour, and a second incubation in 1 X PBS overnight at 
4 ° C. The next day, samples were treated with 10% EDTA for one hour, then received 
three washes with fresh sterile 1 X PBS for 30 min each, to be ready for cell seeding 
procedures. 
The tooth slice/scaffold devices were prepared from freshly extracted teeth, cleaned 
and cut crossectionally as shown in Figure 1. The dental pulp was removed (Figure 
1 D) and a PLLA scaffold was cast in the pulp chamber (Figure 1 E, F). 
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Figure 1: (A) and (B) Freshly extracted teeth are cut into lmm tooth-slices at the CEJ 
area. (C) and (D) The original pulp tissue is removed preserving the pre-dentin. (E) 
PLLA scaffolds are fabricated inside the pulp chamber space. (F) Bright field image of 
tooth slice/scaffold, 200X. 
21 
D. Cell Seeding inside the tooth-scaffold devices 
The surface area and volume of scaffold inside the teeth were calculated to determine the 
number of cells needed per sample. Our standard scaffold is 6x6xlmm. In the area of 
36mm3 we know we should seed 1 x 106 cells, according to established protocol (Nor et 
al., 2001). We classified the sliced teeth into small pulp chambers and large pulp 
chambers, seeding approximately 5x105 for the large pulp chambers and 3.3xl 05 for the 
small pulp chambers (Figure 2). 
Cells are trypsinized, detached from the flasks, and centrifuged for five minutes at 800 
rpm. They are resuspended for cell counting. Fifty micrometers of Trypan Blue Stain is 
added to 50J.Lm of resuspended cells and are placed in the hemocytometer for counting, 
under the microscope. Matrigel® was used in a 1:1 proportion along with cell medium in 
the cell pellet as described by Nor et al., 2001. 
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Figure 2: Tooth-slices were classified into large pulp chambers and small pulp chambers. 
The area and volume are calculated to better estimate the amount of cells we should seed 
into the different samples. Our standard is the 6x6xlmm scaffold, with lx106 cells. Large 
pulp chambers receive 5x105 and small pulp chambers, 3.3x105• 
23 
In Vitro Study 
E. Sample preparation for Image capturing: 
A protocol was developed and optimized to determine a concentration of the fluorescent 
dye that can be used to label cells with minimal toxicity. Long term cell labeling tracers 
were used to stain dental pulp stem cells (DPSC) in green fluorophore with 
carboxyfluorescein diacetate succinimidyl ester (CFDA SE®), and simultaneously label 
dental pulp fibroblasts (DPF) in red fluorophore with carboxy SNARF®l. The tooth-
scaffold samples that received pre-stained cells were treated with two 30 min washes of 
HBSS (Hank's Balanced Salt Solution) without Magnesium and Calcium in the 
humidified C02 incubator at 37 ° C. To evaluate cellularity, a proliferation assay is 
assessed over time, collecting data at days zero, one, three and five. The samples are 
assessed for cellular density with samples under inverted microscopy with Leica 
Sotfware Immaging System, as well as confocal laser microscopy (Nikon). Cell count is 
performed with manual tag on the pictures using the Image-Pro Software 
(MediaCybemetics, Inc., Bethesda, MD). 
After seven days, images of co-culture in tooth-scaffold devices showing CFDA SE® 
green cell tracer dye in DPSC and SNARF®l red cell tracer dye in DPF were obtained 
with inverted confocal laser microscopy (Olympus), as well as samples that had single 
cell population with each cell type. Empty controls without cells were also evaluated in 
this experiment. 
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In Vivo Study 
Severely immunodefficient (SCID) mice (CB.17 SCID; Charles River, Wilmington, MA) 
were anesthetized with a solution of ketamine®/xylazine®, and received a 1 em long 
incision in the dorsum. Bilateral subcutaneous pockets were created to separate the 
dermis from the underlying muscular layer, as described by Gon¥alves et at., 2007. These 
pockets in the dorsum region received two tooth slice/scaffold devices (one on each side), 
with the dental pulp cells seeded in the following groups: DPSC alone, DPSC with DPF, 
DPF alone and empty devices. After 21 days, the mice were euthanized and samples 
were retrieved for analysis. The use and handling of animals in this study were 
performed in accordance with UCUCA and ULAM guidelines. 
F. Hematoxylin & Eosin Histology 
Each sample was fixed in 10% buffered formalin for 24 hours at 4° C, demineralized with 
10% formic acid for several days at 4° C, until the dentin didn't offer resistance to being 
cut for histology. Histological procedures preparing paraffin blocks for histological cuts 
of 5).lm in slides (according to Saw et al., 2004) were prepared for analyses with 
hematoxylin and eosin staining. Some slides were left unstained for 
immunohistochemistry (Factor VIII). 
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G. Immunohistochemistry 
Factor VIII Immunohistochemical analysis was performed using DAKO Cytomation 
EnVision + System-HRP (AEC) with Rabbit Primary Antibodies. Samples were 
incubated with (F. VIII related antigen Ab-1 Rabbit PAb ref. RB-281-A; antibody 
diluent- ref. S0809, 1 :500) polyclonal rabbit anti-human Von Willebrand Factor for 30 
min at room temperature. Sections were washed with lX PBS, and incubated in the 
second antibody (Labelled Polymer-HRP, anti-rabbit DAKO, ref. 4008,) for 30min at 
room temperature. Sections were washed with IX PBS and AEC substrate chromogen 
(Dako ref. K 4008) was applied for 5 min. Sections were counterstained with 
hematoxylin, washed with distilled water and observed under light microscope at 200X 
magnification. 
G. Statistical Analysis 
Statistical analysis was performed using One Way ANOVA followed by Tukey Tests for 
multiple group comparison with SIGMASTAT 2.0 statistical software (SPSS, Chicago, 
IL, USA). The level of significance was determined at P:::; 0.05. 
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4. Results 
In vitro studies 
The in vitro culture of dental pulp stem cells inside the tooth-scaffold system was 
observed through the use of fluorescent Cell Tracker Green showing viable cells in 
a laboratory fabricated environment inside the pulp chamber space of a sliced tooth 
(Figure 3). 
Dentin and PLLA scaffold retained some fluorescent staining and the experiment 
design was changed to observe cells only in the teeth-scaffold system. We also 
wanted to be able to tell the cell populations apart (i.e. DPSC and DPF), to 
understand their spatial distribution within the pulp chamber. 
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Figure 3: (A) Tooth-scaffold stained with Cell Tracker Green (lOOX). (B) Empty control 
shows that dentin and PLLA scaffold retain some fluorescent staining (200X). 
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For long term cell labeling systems we used carboxyfluorescein succinimidyl ester CFDA 
SE® and carboxy SNARF®-1 (Molecular Probes, Inc.), which is able to trace cells for up 
to 7 days in vitro (Figure 4). 
The cell tracer for dental pulp stem cells (DPSC) was an amine-reactive 
carboxyfluorescein succinimidyl ester, of color green called CFDA SE®. It passively 
diffuses into cells, reacts with intracellular amines and forms fluorescent conjugates. The 
label is inherited by daughter cells after cell division and is not transferred to adjacent 
cells (Magg and Albert, 2007) (Figure 4A). 
SNARF®-1 is the long wavelength fluorescent that we used for the dental pulp 
fibroblasts (DPF). The cells were pre-stained with the green and red fluorescent probes 
and then seeded inside the tooth/scaffold device. The experimental conditions tested 
were: dental pulp stem cells alone, dental pulp stem cells with dental pulp fibroblasts, 
dental pulp fibroblasts alone and empty control samples. The tooth slice/scaffold devices 
with single cell population received 5x105 cells, and the dual culture system received 
2.5x I 05 per cell type (Figure 4B). 
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Figure 4: (A) DPSC were stained with CFDA SE® and (B) DPF were stained with 
SNARF-1®. (400X) 
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The concentrations of the probes were tested separately for each cell type to determine 
cell viability and long term maintenance of the immunofluorescent label. DPSC were 
seeded in 24 well plates (n=12 - 2x104 cells per well) with different concentrations 
ranging as follows: [25], [20], [15], [1 0], [5], [2.5] ~M 
To assess the number of viable cells after they were stained, a Trypan Blue assay was 
conducted within 24 hours after the dye was applied. Cells were counted with the 
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Figure 5: A working concentration of IO~M is found adequate to be used with DPSC for 
experiments after one week under fluorescent microscopy. Similarly, a working 
concentration of 1 ~M was found adequate to be used with DPF. 
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The proliferation assay was conducted for five consecutive days with 40 samples, and the 
results are shown in Figure 6. The description of the experiment design for the 
proliferation assay is to evaluate cell density of different cell groups within the tooth-
scaffold devices. The experiment was conducted for five days. Pictures of three random 
fields of each sample for each cell group was taken at days zero, one, three and five. To 
obtain pictures, samples were washed twice with 30 min washes of Hank's Balanced Salt 
Solution (HBSS) for background elimination. After the fluorescence excitation happens 
in the cells and samples are exposed to UV light, light is emitted through exposure for 
picture taking and samples can no longer be used. Pictures of three random fields at 400X 
were taken of each sample, each day. 
The cell groups tested in the proliferation assay were: DPSC alone, DPSC with DPF and 
DPF alone. Each group tested had 12 samples (n=36) plus the empty control group (n=4). 
Total n=40. The experiment was repeated. 
After 5 days, cell density inside the system remained constant when DPSC and DPF were 
seeded together, in vitro (Figure 6). DPSC+ DPF showed a significantly higher cell 
number after 5 days as compared to the experimental conditions where we had one cell 
type only (i.e. DPSC or DPF). 
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Figure 6: Overall Cell number according to time and culture condition, i.e. DPSC only, 
DPF only and DPSC + DPF co-cultures. (*, p < 0.05). 
The confocal laser microscopy was a separate experiment conducted after seven days and 
had 16 samples. Images were obtained 7 days after seeding suggests morphological 
changes of DPSC when co-cultured with DPF. DPSC appears to extend cytoplasmic 
processes inside the surrounding dentinal tubules, suggesting an odontoblast-like 
morphology (Figures 7 and Figure 8). Such images are not observed in single cell type 
scaffolds (Figure 9) or empty scaffolds (Figure 1 0). 
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Figure 7: At 7 days in vitro, Confocal Laser Microscopy, immunofluorescence of dual 
stained samples. (A) DPSC stained with CFDA SE®. (B) DPF stained with SNARF® 1. 
(C) Merged image of both cells on the same sample, showing cellular processes going 
inside dentinal tubules. lOOX. (Total n=16) 
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Figure 8: This shows a sliced image of cellular processes in the dentinal area at 7 days in 
vitro, where on the right and bottom images we see with cross section the cells inside the 
tubules. 400X 
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Figure 9: Image of samples with single cell population, where cells were stained with 
dyes and are shown in bright field background. DPSC in green, DPF in red, 400X. 
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Figure 10: Empty control sample, with green filter on the top left, red filter on the top 
right, and bright field on the center. 400X 
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In vivo studies 
Tooth scaffold samples were transplanted in SCID mice (Figure 11 A- E). After three 
weeks, mice were euthanized and implants were retrieved (Figure 11 F; Figure 12). 
Descriptive Histology 
Empty tooth-scaffold devices presented histological features of loose connective tissue, 
well populated with fibroblast cells, with a moderate amount of blood vessels (Figure 13 
C). The DPF group presented loose connective tissue formed, fairly vascularized (Figure 
13 B). The DPSC group presented with loose connective tissue formation (Figure 13 D). 
Finally, the DPSC+DPF group had a denser and more fibrous connective tissue present 
(Figure 13 E). 
The present study formed tissue in vivo inside the pulp chamber of sliced teeth, seeding 
dental pulp stem cells, dental pulp fibroblasts, both cells and no cells into a biodegradable 
PLLA scaffold that was built inside the pulp chamber space of the sliced tooth. The cells 
that lined the pre-dentin area had some morphological resemblance to the odontoblastic 
layer as found in normal dental pulp (Figure 13 A). These cells were counted under light 
microscopy. We observed that the average number of cells lining the pre-dentin is 
significantly higher in the group with DPSC and DPF, as compared to the DPSC alone, 
DPF alone and Empty Control experimental conditions evaluated here (Figure 14). 
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Figure 11: Tooth scaffold devices were prepared and seeded with cells. Four groups were 
tested: (A) Empty controls, (B) DPSC, (C) DPF, (D) DPSC+DPF (total n=16). 
The experiment was repeated (total n=16). (F) Samples were retrieved after three weeks. 
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Figure 12: Implants after three weeks. (A) Empty Control; (B) DPF; 
(C) DPSC + DPF and (D) DPSC. 
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Figure 13: Hematoxylin & Eosin staining of engineered dental pulps (200X). (A) Positive 
control with a regular dental pulp, (B) engineered tissue using DPF, (C) engineered tissue 
from the empty control sample, (D) engineered tissue with DPSC, (E) engineered tissue 
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Figure 14: Number of cells lining the pre-dentin according to experimental conditions 
after 21 days implantation in the dorsal subcutaneous ifSCID mice.(*, p< 0.05). 
(Total n=16). 
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Microvessel Density of tissues formed 
Microvessel density was assessed after immunohistochemistry with Factor VIII. 
We observed that the microvessel density is significantly higher in the groups DPSC + 
DPF and DPSC only, as compared to DPF only, or the empty scaffold controls (Figures 
15 and 16). 
Figure 15: Factor VIII immunohistochemistry: (A) Positive Control: human pulp tissue; 
(B) Engineered tissue with DPSC + DPF; (C) Empty Control (implanted without seeded 
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Figure 16: Microvessel density in engineered dental pulps, according to experimental 
conditions.(*, p< 0.05). (Total n=16). 
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5. Discussion 
In this study we attempted to begin the characterization of engineered dental pulp tissues. 
In our in vitro experiments we studied the spatial distribution of cells (i.e. DPSC and 
DPF) in the scaffolds. Cell density and its spatial distribution inside the tooth-scaffold 
devices were evaluated over seven days. 
A significant in vitro finding is revealed by cellular behavior from single cell population 
cultures to the co-culture situation, where we only observe cytoplasmic processes when 
we have both cells interacting together (total n= 16). DPF cells are responsible for 
secreting collagen as an extra cellular matrix for protein synthesis and a sequence of 
morphogens such as fibroblast growth factor (FGF), and VEGF and others (Tran-Hung et 
al., 2006) that are relevant for tooth morphogenesis, signaling to the DPSC tissue 
specificity related to the dental pulp. Stem cell mediated tissue engineering is maximized 
by tissue specific cells, producing a situation similar to what is found in natural tissues 
where stem cells interact with several other cell types in the tissues where repair and 
regeneration are occurring (Wagers and Weissman, 2004). 
The in vivo results are encouraging to show that the principle of pulp cell therapy in a 
scaffold inside a tooth slice was feasible to generate tissue in the animal model, and the 
tissue morphology evaluated in this study resembles a dental pulp. These results 
corroborate previous data from our laboratory, when dental pulp stem cells from primary 
teeth (SHED) were transplanted into SCID mice in tooth slice/scaffold devices (Cordeiro 
et al., submitted). 
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The findings related to microvascular network formation being significantly higher in the 
co-culture are consistent with data reporting that DPSC population was found intimately 
associated with blood vessels in regular pulp tissues through the identification of several 
markers of the microvascular network (Shi and Gronthos, 2003). This can mean that the 
tissues formed with tooth slice/scaffold devices seeded with DPSC and DPF resemble 
more what is found in regular pulp tissues. 
Before one can attempt to apply these principles into clinical practice, many questions 
will need to be addressed. How to obtain enough vascular supply is vital to maintain an 
engineered tissue. As collagen type I is an important component of dentinal-pulp 
formation (Priam et al., 2005) (Sumita et al., 2006), it would probably be the most 
suitable scaffold for this clinical scenario. 
Platelet-Rich Plasma (PRP) obtained from the patients own blood could be a vehicle to 
provide cell attachment into the scaffold, to be carried into the tooth and remaining pulp 
chamber. PRP has been reported to promote bone regeneration and also play a role in 
suppressing inflammation and stimulating tissue regeneration (El-Sharkawy et al., 2007). 
Several growth-factors active in PRP play a key role in tooth morphogenesis: platelet-
derived growth factors (PDGF-AB and PDGF-BB), transforming growth-factor-B-1, 
insulin-like growth-factor-I, fibroblast-growth-factor (FGF-b), VEGF and others (El-
Sharkawy et al., 2007). Platelet-Rich Plasma has been proven to be an excellent graft 
carrier in bone regeneration procedures, and its gel form at room temperature would 
facilitate cell adhesion into the scaffold. Clinical case reports using bone marrow stem 
cells and platelet growth factor show, through computerized tomography, well integrated 
scaffolds adapted to the cortical bone (Filho Cerruti et al., 2007). 
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Some confounding factors related to the regeneration ability of the patients are 
bacteriological invasion into the remaining pulp chamber and immune response, affected 
by the patient's systemic condition and age. Acceptance of cell therapy in this kind of 
self-contained environment- a tooth cavity with dentinal walls that would not allow 
inflammatory edema to occur, would be dictated by an inflammatory response from the 
host that would be tolerable. Also, occlusal load should be considered carefully, as it 
could mechanically stimulate or affect negatively the regeneration process. Treatment of 
the remaining dentinal walls with 1 0% EDT A without harming the remaining pulp tissue 
could be useful to liberate growth factors involved in cell signaling, using autogenous 
dentin induction to help in the process (Graham, Nor, Smith, et al., 2006). 
With further studies to better understand and orchestrate triggering factors and key 
elements that would stimulate the pulp regenerative process, novel approaches involving 
cell therapy inside a biodegradable scaffold might become an option to offer young 
patients who experienced trauma situations with fractured crowns of permanent teeth. 
This therapy would allow for the completion of root formation and therefore contribute to 
the longevity ofthe tooth (Nor, 2006). Situations where a direct pulp capping is required 
where the degree of pulp inflammation is still reversible, regeneration techniques for pulp 
tissue through cell therapy may become a feasible option to preserve pulp vitality and 
help stop the destructive process of the tooth organ. 
Nevertheless, the principle of engineering a tissue with cellularity similar to the dental 
pulp inside the pulp chamber space of sliced teeth has been proven possible in the SCID 
mice model. The in vitro findings of cellular disposition with cytoplasmic processes 
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extending inside the dentinal tubules are encouragmg to suggest that odontoblastic 
differentiation might be occurring. 
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6. Conclusions 
Within the limitations of this study, we conclude that: 
1. The visualization of DPSC and DPF with long term cell labeling through confocal 
laser microscopy seemed adequate to assess cellular density and spatial 
distribution of cells within tooth slices. 
2. Cytoplasmic processes inside dentinal tubules observed in the co-culture samples 
after 7 days in vitro are suggestive of the presence of odontoblast like cells in the 
engineered dental pulp. 
3. Co-implantation of DPSC and DPF seeded in tooth slice/scaffold devices into the 
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A. Cell Culture: 
Human Dental Pulp Stem cells 
Medium: 75ml flasks 
Laboratory Protocols 
• 500ml oflow glucose Dulbecco's Modified Eagle Medium (DMEM)+ 
• 50ml (10%) Fetal Bovine Serum (Gibco), 
• 5.5ml (1 %) of Penicillin/Streptomycin 
Freezing Medium: 
• 45ml ofFBS (90%) 
• 5ml ofDMSO (10%) 
Keep in 4 Falcon flasks: ~12ml each 
Cells are kept in a humidified C02 incubator at 37 ° C. Medium was changed every other 
day. 
When cells reach about 70% of confluency (after 2 to 3 days), they are detached from the 
75ml flasks with: 
1. 4ml Trypsin wash and quick shake in flask, aspirate right away. 
2. 2ml Trypsin for 3 min in incubator, gently tapping the flask to help detach the 
cells. 
3. 4ml of medium to neutralize trypsin, transport the cells to a falcon tube. 
4. Centrifuge in program 1 for 5 min. 
5. Aspirate liquid from cell pellet. 
6. Resuspend cells in medium: 1ml per flask (usually pass at a proportion of 1:3 
flasks). 
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7. New flasks are filled with 9ml of medium when cells are transported to it. 
8. Change medium the next day to eliminate trypsin toxicity from medium. 
To freeze, centrifuge and resuspend with freezing media: lml per vial tube. 
Human Dental Pulp Fibroblasts 
Medium: 75ml flasks 
• 500ml ofhigh glucose Dulbecco's Modified Eagle Medium (DMEM)+ 
• 50ml (10%) Fetal Bovine Serum (Gibco), 
• 2. 75ml of Penicillin/Streptomycin 
• 5.0 ml ofL-Giutamine 
Freezing Medium: 
• DMSO: 5ml 
• Medium: 40ml 
• FBS: 5ml 
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B. Scaffold Fabrication Inside the Teeth Slices: 
The technique was developed to prepare polymer scaffolds inside the canal of the tooth 
slice is described below: 
5% Poly-L-lactic acid (PLLA) scaffolds were prepared inside the canal space of a sliced 
tooth. The description of this protocol is in the appendix section 
Materials: 
NaCl (sieved 2501J.m, Sigma) 
5% Poly-L-lactic acid (PLLA, Resomer®, BOEHRINGOR INGELHEIM) 
Chloroform by J T Baker, in I OOml glass beakers. 
Parafilm®, by Pechiney Plastic Packaging (Menasha, WI) 
Methods: 
Day 1: prepare a 5(w/v) % solution of PLLA of PLLA in chloroform: 1 g PLLA in 20m! 
chloroform, using glass pipettes. Leave it covered with poked parafilm overnight to 
evaporate the chloroform. 
Day 2: Teeth slices are dried in sterile gauze, placed in a glass slab and NaCI was 
sprinkled inside the canal area. Drops of PLLA are applied on top of the NaCI, letting it 
soak in and fill the canal space. Excess material is cleaned off the dentin area. The 
procedure is repeated on the other side of the slice, trimming excess material, sprinkling 
NaCl and PLLA until the canal space is completely filled with the materials. The 
samples are placed inside the beakers to allow the setting of the polymer overnight, 
covered with poked parafilm. 
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Day 3: Wash the samples with PBS-IX to solubilize the NaCI for two days, changing 
PBS-IX four times a day. 
Samples are maintained in PBS-IX at 4° C, in 24 well plates. 
Prior to using the samples for experiments, a final check on excess material outside of the 
canal area of the tooth slices is performed with a scalpel # 15 and sterile gauze, returning 
the samples to the wells with PBS-I X at 4° C. 
Day I: Three-dimensional samples of tooth slice/scaffolds are prepared and sanitized in 
I 00% ethanol for I 0 min, 90% ethanol for I Omim, 80% ethanol for I 0 min, 70 % ethanol 
for I 0 min, sterile PBS-IX for I hour, changed PBS-IX to spend overnight at 4 ° C. 
Day 2: The samples are treated with I 0% EDTA for one hour, then receive three washes 
with fresh sterile PBS-I X for 30 min each, and are ready for cell seeding procedures. 
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C. Cell density inside the tooth slice devices: 
Cell seeding quantity was determined with the following calculations: 
Maxillary molars (n=1 0): 
V= 0.77 x 6.27 x 1.4 = 6.76 mm3 
A=29.38 mm3 
Mandibular molars (n=IO): 
V= 0.71 X 4.52 X 3.57 = 11.46 mm3 
A= 43.76 mm3 
Scaffold: (as standard) 
V= 1 X 6 X 6 = 36 mm3 
A=96mm3 
V=hXwXd A= 2wd + 2dh + 2hw 
As we know we can seed in the standard scaffold (6x6xl): lxlO, we determined that: 
6 
Small pulp chambers: we seed 3.3 x 10
5 
Large pulp chambers: we seed 5 x 10
5 
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D. Seeding cells in Matrigel® inside the tooth-scaffold devices 
1. Preparing cells to be seeded 
Materials: 
• DPSC and DPF (primary cell lines, passages 5-8) in 150m! flasks 
• DMEM low glucose and high glucose media, respectively, at 37°C 
• Trypsin, 37°C 
• Trypan Blue Stain 0.4% 
Methods: 
• Trypsin wash the cells: 8ml 
• Incubate cells in 4ml of Trypsin for 3-5 min at 37°C 
• Neutralize Trypsin with 8ml of media 
• Collect 12m! to be centrifuged for 5 min, 800 rpm (program l) 
• Aspirate extra media, leave cell pellet in the bottom 
• Resuspend cells in 4ml media 
• Obtain 50f..Ll of resuspended cells+ 50f..Ll ofTrypand Blue 
• Count cells with hemocytometer: A+B+C+D/4= X x 104 per ml (x 4 ml of 
resuspension. 
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2. Seeding cells into the teeth-scaffolds devices 
Materials: 
• Vials with cell pellets, on ice 
• Matrigel®, on ice 
• PLLA scaffolds, previously sanitized in ethanol grades, washed 3X in IX-PBS 
Methods: 
• After counting, distribute resuspended cells in aliquots of the desired quantity of 
5cells in individual vials (5x 105 per tooth/scaffold sample) 
• New centrifuge of I 000 rpm for 1 minute to obtain a cell pellet 
• Aspirate excess media and leave 9J.11 of media with pellet 
• Add 9J.11 of Matrigel® to the mix, take it to the scaffold 
• Leave in incubator for 30min. 
• Transport samples in well plates on ice to be implanted subcutaneously in SCID 
mice, two samples per mice. 
62 
E. In Vitro Experiment Design: 
Cut teeth slices. 
Prepare samples of teeth-scaffold for each cell group: DSPC, DPF, SC+F, Empty Control 
Sanitize them in alcohol grades from I 00%, 90%, 80% and 70% for I 0 min each, one 
hour of PBS wash, fresh PBS overnight. 
Next day, treat them with EDTA IO% for one hour prior to seeding, IX- PBS washes 
three times, each 30 min. 
The seeding ofthe cells in scaffold will happen on the "base line" day and I distribute 
evenly the same amount of cells in different vials. 
I. Stain both population of cells with respective probes in PBS for 40 min, obtain pellet 
2. Wash pellets twice in warm media for 30 min (first 30 min interval in incubator) 
3. Seed cells in tooth/scaffold sample in Matrigel®. 
4. Incubate for one hour. 
5. Add media to the samples. 
6. Labtech® 2 well covered chambers will hold the samples for each cell group. 
7. Cover the samples with foil, change media every other day. 
To ensure quality of pictures I treat them with HBSS twice for 30 min before acquiring 
pictures. Samples are discarded after image capture: three fields on each sample at 400X. 
To measure: 
Quantification of cells overtime 
Cellular disposition on tooth/scaffold structure 
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F. Methodology for Long Term Cell Labeling Probes 
A protocol was developed and optimized to determine a concentration of the fluorescent 
dyes that can be used without being harmful and toxic to cell survival. 
After determining a working concentration of lOJ.!M for CFDA SE (green dye) and lJ.!M 
for SNARF®l (red probe), experiments were performed to evaluate cell survival over a 
period of five days, where images are captured at days zero, one, three and five. 
The samples are previously treated with 2 washes of 30 minutes of HBSS (Hank's 
Balanced Salt Solution) without Magnesium and Calcium in the humidified C02 
incubator at 37 ° C, before undergoing UV light in inverted microscopy for image 
capturing. 
At seven days, with inverted confocal laser microscopy (Olympus), images were obtained 
of the samples with co-culture of DPSC and DPF, as well as samples that had single cell 
populations with each cell type, and empty controls without any cells in it. 
I. Carboxy Fluorescein Succinimidyl Ester (CFDA SE®) green fluorophore 
Molecular Probes give you a wide range of working concentration of the dye for you to 
try in the specific cells you are working with: 0.5-25J.1M 
MW= 557.47 
Prepare a 1 OmM CFDA SE stock solution immediately prior to use by dissolving 500flg 
(quantity that comes in vial) in 90 Jll of anhydrous DMSO provided in the kit. 
For a concentration of25J.1M I make the calculation: IOmM=IO,OOOf.!M divided by 
25J.1M, gives me a proportion for 1/400J.1M. 
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So, for each 3991J.l of PBS: l~J.l of CFDA SE stock solution- for [25]1J.M. 
2. SNARF®-1 carboxylic acid, acetate, succinimidyl ester red fluorophore 
Carboxy SNARF®-1 is a long-wavelength fluorescent pH indicator developed by 
Molecular Probes. It undergoes a pH-dependent wavelength shift, thus allowing the ratio 
of the fluorescence intensities from the dye at two emission wavelengths to be used for 
more accurate determinations of pH. Excitation ofthe dye happens between 488nm and 
530nm, while fluorescence emission happens at two wavelengths, typically about 580nm 
and 640nm. 
Similarly, the adequate working concentration was found to be 11J.M to be used with 
DPF. The protocol follows: 
Molecular Probes give the following information: 
SNARF®-1 MW: 592.56 
Concentration range given by Molecular Probes: 1-201J.M 
1 vial comes with 501J.g 
50~J.g/l 06 divided by 592.56=Mole/ I 06=0.0844 
M= I mole/ I L= 0.0844/106 divided by 1 x 1 03x 103 = 0.08441J.M 
The concentration ranges from 1 -20~J.M: 





For 201J.M= 4.2189 ml DMSO 
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50J..LM of stock solution in 843.78 J..Ll ofDMSO 
For a volume of 1 ml, a concentration of [1 J..LM], I dilute I OOJ..Ll stock+ 990J..Ll of PBS= 
lml 
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G. Staining DPSC with Carboxyfluorescein Succinimidyl Ester (CFDA SE®) into 
the teeth-scaffold devices 
I. Preparing dental pulp stem cells to be stained 
Materials: 
Sterile IX- PBS 
Stock of I 0~-tM of CFDASE: in vial provided in the kit dilute 90f..d of anhydrous DMSO 
Cell media for DPSC, low glucose DMEM 
Vials with cells, on ice 
Methods: 
• Centrifuge cells and obtain pellet, aspirating supernatant. 
• Concentration of I 0~-tM of CFDASE is required to stain DPSC 
• In falcon tube dilute I 0~-tl ofCFDASE in I 0 ml ofPBS-1 X to obtain the working 
concentration of I 0 ~-tM 
• Resuspend cell pellet in the PBS containing the dye 
• Place in incubator for 30-40 min for 37°C 
• Re-pellet the cells by centrifugation and resuspend in fresh pre-warmed medium. 
• Incubate for another 30 minutes to ensure complete modification of the probe. 
• Wash the cells again in fresh media, 2X 
• Re-pellet to seed cells in scaffolds with Matrigel® 
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2. Seeding cells in Matrigel® inside the tooth-scaffold devices 
The cells were centrifuged again to obtain a pellet to be mixed with Matrigel® and cell 
culture medium in a 1:1. The mix is applied and absorbed by the scaffold inside the teeth. 
The samples are placed inside Labtech® covered chambers inside the incubator at 37 ° C 
for one hour. 
Finally, Dulbecco's Modified Eagle Medium (DMEM; Gibco, Grand Island, NY, USA), 
supplemented with 10% Fetal Bovine Serum (Gibco ), 125 units/ml Penicillin, and 125 
ug/ml Streptomycin are dispensed in the covered chambers where the samples are, 
maintained in a humidified C02 incubator at 37 ° C. Medium was changed every 2 days. 
The samples are covered with aluminum foil because the fluorophore is light sensitive. 
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H. SNARF®l cell labeling for DPF and Seeding in Matrigel® into Tooth-Scaffold 
devices 
I. Preparing dental pulp fibroblasts to be stained 
Materials: 
• DPF (primary cell lines, passages 5-8) in 150ml flasks 
• DMEM High Glucose media at 37°C 
• Trypsin, 37°C 
• Trypan Blue 
Methods: 
• Trypsin wash the cells: 8ml 
• Incubate cells in 4ml of Trypsin for 3-5 min at 37°C 
• Neutralize Trypsin with 8ml of media 
• Collect 12m I to be centrifuged for 5 min, 800 rpm (program I) 
• Aspirate extra media, leave cell pellet in the bottom 
• Resuspend cells in 4ml media 
• Obtain 50J.!l of resuspended cells+ 50J..tl ofTrypan Blue 
• Count cells with hemocytometer: A+B+C+D/4= X x I 04 per ml (x 4 ml of 
resuspension 
2. Staining with SNARF ®I Cell Labelling 
• Centrifuge cells and obtain pellet, aspirating supernatant. 
• Concentration of I J.!M of SNARF I is required to stain cells safely 
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• In stock vial of 50 mg of SNARF 1 dilute 843. 78j.!l of anhydrous DMSO 
(calculations according with MW) 
• For I ml ofpre-warmed PBS-IX add 2 j.!l of stock solution ofSNARF 1 to get 
lj.!M concentration ofthe product. 
• Place in incubator for 40 min for 37°C 
• Re-pellet the cells by centrifugation and resuspend in fresh pre-warmed medium. 
• Incubate for another 30 minutes to ensure complete modification ofthe probe. 
• Wash the cells again in fresh media 
• Re-pellet to seed cells in scaffolds with Matrigel® 
3. Seeding DPF cells into the teeth-scaffolds devices 
Materials: 
• Vials with cell pellets, on ice 
• Matrigel®, in ice 
• PLLA scaffolds, previously sanitized in ethanol grades, washed 3X in IX-PBS 
Methods: 
• After counting, distribute resuspended cells in aliquotes of the desired quantity of 
cells in individual vials (5x105 per tooth-scaffold sample) 
• New centrifuge of I 000 rpm for I minute to obtain a cell pellet 
• Aspirate excess media and leave 9j.!l with pellet 
• Add 9j.!l of Matrigel® to the mix, take it to the scaffold 
• Leave in incubator for 60min Add media to the well 
• Labtech® 2 well covered chambers will hold the samples for each cell group 
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• Cover the samples with foil, change media every other day 
The samples that have both cells in the teeth-scaffold system were stained first and then 
joined at the time of seeding with Matrigel®. 
The seeding of the cells in scaffold will happen on the "base line" day and I distribute 
evenly the same amount of cells in 7 different vials. 
1. Stain cells only with [1;iM] of SNARF@ 1 in PBS for 40 min, obtain pellet 
2. Wash pellets twice in warm media for 30 min (first 30 min interval in incubator) 
3. Seed cells in tooth/scaffold sample in Matrigel@ 
4. Incubate for one hour 
5. Add media to the samples 
6. 2 well covered chambers by Labteck@ plates will hold the samples for each cell group 
7. Cover the samples with foil, change media every other day 
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I. DSP immunostaining Protocol: 
Deparafination: 
1. Xylene 3x for 5 min 
2. 100% Ethanol 3x 1 min 
3. 90% Ethanol5 min 
4. 80% Ethanol for 5 min 
5. 70% Ethanol for 5 min 
6. Rinse in tap water for 5 min 
Endogenous Peroxidase Blockage 
1. Incubate sections for 30 minutes in 3% H202 in methanol, exchanging the liquid 
15 min into it to improve efficacy of peroxidase blockcage. 
2. Wash in buffer twice for 5 min, 2X 
Antigen Retrieval: 
1. Place the samples in flat surface 
2. Add 1 drop ofTrypsin solution A over each slice, 1 drop pfSolution Band one 
more drop of Solution A. 
3. Place slides in humidified incubator at 37°C for 60min 
4. Wash in buffer for 5 min 
Background blockage 
I. Incubate sections for 20 minutes with diluted normal horse serum 
2. Blot excess serum from sections 
Antibody Reactions: 
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1. Apply primary antibody DSP diluted 1:500 in buffer in sections, leave them 
covered overnight at 4°C, then incubate it at 37°C for 30 min. 
2. Wash slides 5 min in buffer 
3. Incubate sections for 30 min with diluted biotinylated "universal" secondary 
antibody 
4. Wash slides twice for 5 min in buffer 
5. Incubate sections for 30 min with VECTASTAIN®R.T.U. ABC Reagent. 
6. Wash slides for 5 min in buffer 
7. Prepare DAB peroxidase solution by adding to 2.5ml of distilled water one drop 
of hydrogen peroxide, one or two drops of substrate reagent (brown stain) and one 
drop of buffer from the DAB kit. 
8. Incubate sections in peroxidase substrate solution until desired stain intensity 
develops (2-1 0 min). Watch the reaction in microscope and when desired stain is 
obtained, stop the reaction with distilled water. 
9. Counterstain slides with Hematoxilyn 
I 0. Rinse sections in tap water. 
11. Mount with coverslides in aqueous mounting media. 
12. Seal with nailwear. 
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